Your browser doesn't support javascript.
loading
The development of stereotactic body radiotherapy in the past decade: a global perspective.
Lo, Simon S; Slotman, Ben J; Lock, Michael; Nagata, Yasushi; Guckenberger, Matthias; Siva, Shankar; Foote, Matthew; Tan, Daniel; Teh, Bin S; Mayr, Nina A; Chang, Eric L; Timmerman, Robert D; Sahgal, Arjun.
Afiliação
  • Lo SS; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Slotman BJ; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Lock M; Department of Radiation Oncology, London Regional Cancer Program, University of Western Ontario, London, ON, Canada.
  • Nagata Y; Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan.
  • Guckenberger M; Department of Radiation Oncology, University of Zurich, Zurich, Switzerland.
  • Siva S; Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
  • Foote M; Department of Radiation Oncology, Princess Alexandra Hospital, School of Medicine, University of Queensland, Queensland, Australia.
  • Tan D; Asian American Radiation Oncology, Singapore.
  • Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX, USA.
  • Mayr NA; Department of Radiation Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chang EL; Department of Radiation Oncology, Keck School of Medicine & Norris Cancer Center at the University of Southern California, Los Angeles, CA, USA.
  • Timmerman RD; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Sahgal A; Department of Radiation Oncology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada.
Future Oncol ; 11(19): 2721-2733, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26338676
ABSTRACT
In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Future Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Future Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos